Bioprinting the Lymph Node to generate antibodies against COVID-19
Bioprinted lymph node to generate antibodies against SARS-CoV-2 (credit to Prellis Biologics) Race against COVID-19 Since the pandemic, biotech and pharmaceutical companies are racing to develop diagnostic kits, vaccines and treatments to combat COVID-19. Antibodies, more specifically neutralizing antibodies that can bind to the virus, can help reduce and prevent infection against SARS-CoV-2. This can serve as a prevention for those of us who have not yet been infected or after recovery and reduce effects of those who are infected and in the road to recovery. Now, some of you might wonder, so how is bioprinting going to help create antibodies? Bioprinting a Synthetic Lymph Node Enter Prellis Biologic s, a Bay Area early-stage venture backed bioprinting company who proposed that they can bioprint a synthetic mini lymph node that will induce immune cells to create human antibodies that are effective against SARS-CoV-2. The beauty of this approach is that there is no ne...